With You Every Step Of The Way.

Regulatory Strategy Development

• Identification of optimal regulatory pathways (FDA, EMA, PMDA, etc.)

• Pre-IND/Pre-Submission meeting preparation

• Regulatory risk assessment and mitigation strategies

Market & Competitive Analysis

• Identification of market needs and competitive positioning

• Pricing and reimbursement strategy development

Intellectual Property (IP) Strategy

• Patent landscape analysis and freedom-to-operate assessments

• IP filing strategy in alignment with commercialization goals

Toxicology & Safety Studies

• GLP and non-GLP toxicology studies (acute, chronic, reproductive, carcinogenicity)

• Genotoxicity, immunotoxicity, and neurotoxicity studies

Pharmacokinetics (PK) & Pharmacodynamics (PD)

• In vitro and in vivo ADME (Absorption, Distribution, Metabolism, and Excretion)

• PK modeling and bioavailability assessments

Proof-of-Concept (POC) Studies

• Early feasibility studies in relevant animal models

• Mechanism of action validation

Regulatory Submissions

• IND, IDE, NDA, BLA, 510(k), PMA, De Novo, Breakthrough Device Designation

• Compilation, publishing, and submission via eCTD

Health Authority Interactions

• Meeting planning and briefing document preparation (FDA, EMA, MHRA, etc.)

• Responses to regulatory queries and deficiency letters

Quality & Compliance Support

• GxP compliance consulting (GLP, GCP, GMP)

• SOP development and training

Clinical Development Strategy & Study Design

• Clinical protocol development and study feasibility

• Endpoint selection and statistical power calculations

• Site and investigator selection strategy

Clinical Trial Management

• Phase I (First-in-Human)Dose escalation, safety monitoring, and PK studies

• Phase II (Efficacy & Safety)

• Proof-of-concept trials, biomarker assessments

• Phase III (Pivotal Trials)

• Multinational large-scale trials, patient recruitment optimization

• Phase IV (Post-Marketing)Real-world evidence (RWE), observational studies, registry studies

Clinical Operations & Monitoring

• Site selection, activation, and patient recruitment

• Clinical monitoring (on-site and remote)

• Risk-Based Monitoring (RBM) and adaptive trial oversight

Data Management & Biostatistics

• Database design, EDC implementation

• Data collection, validation, and cleaning

• Statistical analysis plan (SAP) and clinical trial reporting

OUS Study Support

• Local sponsorship (Australia)

• TGA submissions

• HREC submissions

• Full clinical trial support

• Protocols, Investigator’s Brochures (IBs), and Clinical Study Reports (CSRs)

• IND/NDA/BLA/510(k) submission documents

• Lay summaries for regulatory and patient engagement

• Publications and scientific communications

Reimbursement & Health Economics (HEOR)

• Value proposition development and payer engagement

• Cost-effectiveness modeling and market access planning

Regulatory Post-Market Compliance

• Pharmacovigilance and medical device vigilance (PMCF, PMS reports)

• Post-market surveillance and adverse event monitoring

Commercial Strategy Development

• Key opinion leader (KOL) engagement and medical affairs support

• Sales training and commercial launch strategy

• AI-driven protocol optimization and patient recruitment analytics

• eCOA/ePRO solutions for patient-reported outcomes

• Real-world data (RWD) and real-world evidence (RWE) analytics